Grants and Contributions:

Back to search

Title:

Combinatorial therapeutic strategy for hypoxic solid tumor through modulation of redox homeostasis

Agreement Number:

1002422

Agreement Value:

$24,203.00

Agreement Date:

Mar 22, 2023 - Dec 31, 2025

Description:

Advances exploratory research under the New Beginnings Initiative

Organization:

National Research Council Canada

Expected Results:

In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators.

Location:

Vancouver, British Columbia, CA V5Z 1L3

Reference Number:

172-2022-2023-Q4-1002422

Agreement Type:

Grant

Report Type:

Grants and Contributions

Recipient Business Number:

863530135

Recipient Type:

Not-for-profit organization or charity

Additional Information:

This agreement has been amended 2 time(s). The end date of this agreement has been modified by 92 days.

Amendment Date

May 26, 2025

Recipient's Legal Name:

BC Cancer, part of the Provincial Health Services Authority

Federal Riding Name:

Vancouver Granville

Federal Riding Number:

59038

Program:

Collaborative Science, Technology and Innovation Program – Ideation Fund

Program Purpose:

The Ideation Fund is intended to encourage, test and validate transformative research ideas generated by teams of NRC scientific personnel and external collaborators with complementary capabilities, acting as a demonstration phase for a continually-evolving suite of research and development (R&D) deliverables at the NRC. The fund supports exploratory research through two mechanisms: the New Beginnings Initiative and the Small Teams Initiative.

NAICS Code:

541710

Amendments:

See Amendments